Efficacy and Safety of Eculizumab in Enteroaggregative <i>E. coli</i> Associated Hemolytic Uremic Syndrome

Efficacy and Safety of Eculizumab in Enteroaggregative <i>E. coli</i> Associated Hemolytic Uremic Syndrome

Background. Hemolytic uremic syndrome (HUS) may present atypically without the full triad of classical HUS. Eculizumab has been shown to be efficacious in complement-mediated atypical HUS and some cases of Shiga-toxin (ST) associated HUS. We report the utility of eculizumab in enteroaggregative <...

Full description

Bibliographic Details
Main Authors: Ratna Acharya, William L. Clapp, Kiran Upadhyay
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pediatric Reports
Subjects:
hemolytic uremic syndrome
eculizumab
enteroaggregative
<i>E. coli</i>
children
Online Access:https://www.mdpi.com/2036-7503/16/1/3

Internet

https://www.mdpi.com/2036-7503/16/1/3

Similar Items